FDA chief Gottlieb blames drugmakers for ‘anemic’ biosimilar market
admin 19th July 2018 Uncategorised 0The FDA has so far approved 11 biosimilars, but only three are currently sold in the U.S. FDA Commissioner Scott Gottlieb, M.D., is now blaming developers of the original reference biologics for the “anemic” biosimilar competition.
More: FDA chief Gottlieb blames drugmakers for ‘anemic’ biosimilar market
Source: fierce